The number of Hospital Supplies pipeline products in 2020 saw a 779% rise globally when compared to Hospital Supplies pipeline products in 2019, according to GlobalData’s pipeline products database. This compares to an 34% rise for all pipeline medical devices in 2020 compared to 2019.
The global Hospital Supplies market was worth $153.33bn in 2019 and is expected to reach $133.22bn by 2025, according to GlobalData’s analysis.
Hospital Supplies pipeline products by categories: Personal Protective Equipment has the most devices
Looking at the device categories of pipeline products, Personal Protective Equipment accounted for the largest proportion (15.45%) in 2020, followed by Syringes, Needles and Urinary Catheters (5.69%) and Patient Examination Devices (3.25%).
Of the global medical devices market value, the Hospital Supplies market held a 32% share worth $153bn in 2020 and is expected to reach $133.22bn by 2025.
Hospital Supplies development activity: Advanced stage of development leads
Devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe or the rest of the world) accounted for 36.29% of medical devices in 2020, compared with 35.71% in 2019. The number of devices at the In Approval stage inclined by 1200% in 2020, when compared with 2019.
The In Approval stage is considered to be the period where the manufacturer is waiting for final approval from regulators, following completion of the required development steps.
A decrease in products awaiting approval would indicate less new products entering the market in the coming months, while an increase indicates more devices entering the market, posing a market share threat to existing marketed devices.
North America tops pipeline Hospital Supplies products activity
Comparing the number of pipeline Hospital Supplies products activity in different regions of the globe, North America held the top position (58%) during 2020, followed by Asia-Pacific (23%), and Europe (16%).
On a country level, the US had the most pipeline Hospital Supplies during the year, representing the largest share (61%) of Hospital Supplies pipeline products. In second place was India (23%), followed by Canada (7%).
New pipeline Hospital Supplies medical devices: Expected to be approved by 2025
According to GlobalData, approximately 15% of pipeline Hospital Supplies in 2020 were expected to receive regulatory approval by the end of 2025. The leading categories for devices expected to receive regulatory approval by the end of 2025 was Stethoscopes, at 0% of devices. Differences in regulatory approval timelines reflect the stage of development for a device, the device complexity or risk categorization (or device class) or if there are changes in regulatory oversight.
Indian Institute of Technology Delhi tops Hospital Supplies development in 2020
According to GlobalData, top ten medical device companies accounted for 21.14% of pipeline Hospital Supplies activity during 2020. The leading company for developing Hospital Supplies was Indian Institute of Technology Delhi with 3.25%, followed by Indian Institute of Technology Guwahati at 2.44%.
Companies launching new medical devices are more likely to disrupt existing market share or are better able to defend existing share.
Company-developed pipeline products lead Hospital Supplies in development
Looking at the share of activity in terms of Hospital Supplies pipeline products developers, company-developed pipeline products accounted for a 57% share of the Hospital Supplies medical devices market, while institute-developed pipeline products held the remaining share.
The monthly average for 2020 saw company-developed Hospital Supplies pipeline products account for 57% of pipeline products and institute-developed pipeline products account for 43%.
The medical devices pipeline data used in this article were extracted from Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database covers all medical devices which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. Pipeline products are covered from various authenticated sources like company websites, SEC filings, conference presentations, analyst presentations, news releases, grants etc. The information is collected by following systematic research techniques and proprietary methodology.